FAIR VALUE OF FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)
|
3 Months Ended |
9 Months Ended |
12 Months Ended |
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Jun. 30, 2025 |
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
$ 63,037,631
|
[1] |
|
$ 63,037,631
|
[1] |
|
$ 85,016,596
|
[2] |
| Amortized Cost |
|
69,812,379
|
[3] |
|
69,812,379
|
[3] |
|
88,404,806
|
[4] |
| Structuring fees |
|
19,091
|
|
$ 125,000
|
109,092
|
|
$ 227,705
|
|
|
| Accelerated original issue discounts due to repayments |
|
0
|
|
33,096
|
57,976
|
|
260,935
|
|
|
| Early repayment income, interest income |
|
0
|
|
0
|
0
|
|
0
|
|
|
| California |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
7,530,677
|
|
|
7,530,677
|
|
|
10,232,607
|
|
| Amortized Cost |
|
7,274,964
|
|
|
$ 7,274,964
|
|
|
$ 10,111,172
|
|
| California | Investments at Fair Value | Geographic Concentration Risk |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| % of Portfolio |
|
|
|
|
11.90%
|
|
|
12.00%
|
|
| South Carolina |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
6,814,722
|
|
|
$ 6,814,722
|
|
|
|
|
| Amortized Cost |
|
6,629,722
|
|
|
$ 6,629,722
|
|
|
|
|
| South Carolina | Investments at Fair Value | Geographic Concentration Risk |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| % of Portfolio |
|
|
|
|
10.80%
|
|
|
|
|
| New Jersey |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
|
|
|
|
|
|
$ 9,158,337
|
|
| Amortized Cost |
|
|
|
|
|
|
|
$ 10,269,586
|
|
| New Jersey | Investments at Fair Value | Geographic Concentration Risk |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| % of Portfolio |
|
|
|
|
|
|
|
10.80%
|
|
| Investment, Identifier [Axis]: Common Equity/Other | ACON IWP Investors I, L.L.C. | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
814,500
|
[1],[5],[6],[7] |
|
$ 814,500
|
[1],[5],[6],[7] |
|
$ 617,500
|
[2],[8],[9],[10],[11] |
| Amortized Cost |
|
472,357
|
[3],[5],[6],[7] |
|
472,357
|
[3],[5],[6],[7] |
|
472,357
|
[4],[8],[9],[10],[11] |
| Investment, Identifier [Axis]: Common Equity/Other | AP Special Sits Camaro Holdings, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[9],[10],[11],[12] |
|
|
|
|
|
|
0
|
|
| Amortized Cost |
[4],[8],[9],[10],[11],[12] |
|
|
|
|
|
|
0
|
|
| Investment, Identifier [Axis]: Common Equity/Other | FullBeauty Brands Holding, Common Stock | Retail |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[6],[7] |
|
0
|
[1],[5],[6],[7] |
|
0
|
[2],[8],[9],[10],[11] |
| Amortized Cost |
|
198,026
|
[3],[5],[6],[7] |
|
198,026
|
[3],[5],[6],[7] |
|
198,026
|
[4],[8],[9],[10],[11] |
| Investment, Identifier [Axis]: Common Equity/Other | New WPCC Parent, LLC (Class A Common Stock) | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
281,898
|
[1],[5],[6],[7],[13] |
|
281,898
|
[1],[5],[6],[7],[13] |
|
142,240
|
[2],[8],[9],[10],[11],[14] |
| Amortized Cost |
|
93,822
|
[3],[5],[6],[7],[13] |
|
93,822
|
[3],[5],[6],[7],[13] |
|
93,822
|
[4],[8],[9],[10],[11],[14] |
| Investment, Identifier [Axis]: Common Equity/Other | QC Holdings Topco, LLC | Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
165,820
|
[1],[5],[6],[7],[15] |
|
165,820
|
[1],[5],[6],[7],[15] |
|
100,000
|
[2],[8],[9],[10],[11],[16] |
| Amortized Cost |
|
100,000
|
[3],[5],[6],[7],[15] |
|
100,000
|
[3],[5],[6],[7],[15] |
|
100,000
|
[4],[8],[9],[10],[11],[16] |
| Investment, Identifier [Axis]: Common Equity/Other | Recovery Solutions Parent, LLC, Membership Interest | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
1,323,260
|
[1],[5],[6],[7],[13] |
|
1,323,260
|
[1],[5],[6],[7],[13] |
|
987,491
|
[2],[8],[9],[10],[11] |
| Amortized Cost |
|
1,085,835
|
[3],[5],[6],[7],[13] |
|
1,085,835
|
[3],[5],[6],[7],[13] |
|
1,085,835
|
[4],[8],[9],[10],[11] |
| Investment, Identifier [Axis]: Common Equity/Other | Research Now Group, LLC & Dynata, LLC (Common Stock of New Insight Holdings, Inc) | Services: Business |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
67,393
|
[1],[5],[6],[7] |
|
67,393
|
[1],[5],[6],[7] |
|
138,718
|
[2],[8],[9],[10],[11] |
| Amortized Cost |
|
282,262
|
[3],[5],[6],[7] |
|
282,262
|
[3],[5],[6],[7] |
|
282,262
|
[4],[8],[9],[10],[11] |
| Investment, Identifier [Axis]: Common Equity/Other | Rising Tide Holdings, Inc., Common Stock | Consumer goods: Non-Durable |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[6],[7] |
|
0
|
[1],[5],[6],[7] |
|
0
|
[2],[8],[9],[10],[11] |
| Amortized Cost |
|
997,560
|
[3],[5],[6],[7] |
|
997,560
|
[3],[5],[6],[7] |
|
997,560
|
[4],[8],[9],[10],[11] |
| Investment, Identifier [Axis]: Common Equity/Other | iQOR Holdings, Inc. (Bloom Aggregator, LP) | Services: Consumer |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
64,461
|
[1],[5],[6],[7] |
|
64,461
|
[1],[5],[6],[7] |
|
75,151
|
[2],[8],[9],[10],[11] |
| Amortized Cost |
|
50,000
|
[3],[5],[6],[7] |
|
50,000
|
[3],[5],[6],[7] |
|
50,000
|
[4],[8],[9],[10],[11] |
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | Emerge Intermediate, Inc. | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[17] |
5,067,485
|
|
|
5,067,485
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[17] |
5,251,280
|
|
|
5,251,280
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien DIP Term Loan A | Automotive |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[6],[7],[18],[19],[20] |
286,774
|
|
|
286,774
|
|
|
|
|
| Amortized Cost |
[3],[6],[7],[18],[19],[20] |
1,087,652
|
|
|
1,087,652
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien DIP Term Loan B | Automotive |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[6],[7],[18],[19],[20] |
2,353
|
|
|
2,353
|
|
|
|
|
| Amortized Cost |
[3],[6],[7],[18],[19],[20] |
3,241,856
|
|
|
3,241,856
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[6],[7],[18],[19],[20] |
6,080
|
|
|
6,080
|
|
|
|
|
| Amortized Cost |
[3],[6],[7],[18],[19],[20] |
1,967,705
|
|
|
1,967,705
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Global Tel*Link Corporation (d/b/a ViaPath Technologies) | Telecommunications |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[21] |
4,874,041
|
|
|
4,874,041
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[21] |
4,822,566
|
|
|
4,822,566
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Healthcare Venture Partners, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[21] |
3,970,000
|
|
|
3,970,000
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[21] |
3,970,000
|
|
|
3,970,000
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Imperative Worldwide, LLC (f/k/a MAGNATE WORLDWIDE, LLC) | Transportation: Cargo |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[21] |
2,943,835
|
|
|
2,943,835
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[21] |
2,898,814
|
|
|
2,898,814
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | New WPCC Parent, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[13],[17],[21],[22] |
1,506,016
|
|
|
1,506,016
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[13],[17],[21],[22] |
1,457,199
|
|
|
1,457,199
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Recovery Solutions Parent, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[13],[21] |
676,522
|
|
|
676,522
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[13],[21] |
416,881
|
|
|
416,881
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Research Now Group, LLC & Dynata, LLC- First Lien First Out Term Loan | Services: Business |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[17],[21],[23] |
1,442,402
|
|
|
1,442,402
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[17],[21],[23] |
1,435,341
|
|
|
1,435,341
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Research Now Group, LLC & Dynata, LLC- First Lien Second Out Term Loan |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[23] |
1,165,267
|
|
|
1,165,267
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[23] |
1,270,672
|
|
|
1,270,672
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | S&S Holdings LLC | Wholesale |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[7],[19],[21] |
2,794,915
|
|
|
2,794,915
|
|
|
|
|
| Amortized Cost |
[3],[7],[19],[21] |
2,928,344
|
|
|
2,928,344
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Shoes West, LLC (d/b/a Taos Footwear) - First Lien Convertible Note to Taos Footwear |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[21],[22],[24] |
322,686
|
|
|
322,686
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[21],[22],[24] |
204,854
|
|
|
204,854
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Shoes West, LLC (d/b/a Taos Footwear) - First Lien Term Loan | Consumer Goods: Non-Durable |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[21],[24] |
4,690,625
|
|
|
4,690,625
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[21],[24] |
4,690,625
|
|
|
4,690,625
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | Verify Diagnostics, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[21],[25] |
2,459,722
|
|
|
2,459,722
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[21],[25] |
2,459,722
|
|
|
2,459,722
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | WatchGuard Technologies, Inc. | High Tech Industries |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[17],[21] |
3,407,773
|
|
|
3,407,773
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[17],[21] |
3,365,963
|
|
|
3,365,963
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan | Automotive | iQOR Holdings, Inc. | Services: Consumer |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[21] |
4,476,697
|
|
|
4,476,697
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[21] |
4,476,697
|
|
|
4,476,697
|
|
|
|
|
| Investment, Identifier [Axis]: Credit Central Loan Company, LLC | Consumer Finance | First Brands Group - First Lien Term Loan1 | Automotive |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[6],[7],[18],[19],[20] |
2,421
|
|
|
2,421
|
|
|
|
|
| Amortized Cost |
[3],[6],[7],[18],[19],[20] |
660,920
|
|
|
660,920
|
|
|
|
|
| Investment, Identifier [Axis]: Druid City Infusion, LLC | First Lien Term Loan |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Investment owned, discount (premium) |
|
|
|
47,727
|
|
|
47,727
|
30,177
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
|
|
$ 99,257
|
|
|
$ 99,257
|
|
|
| Investment, Identifier [Axis]: Preferred Stock | Discovery MSO HoldCo LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
79,317
|
[1],[5],[6],[7],[22],[26] |
|
79,317
|
[1],[5],[6],[7],[22],[26] |
|
68,802
|
[2],[8],[9],[10],[11],[27],[28] |
| Amortized Cost |
|
50,000
|
[3],[5],[6],[7],[22],[26] |
|
50,000
|
[3],[5],[6],[7],[22],[26] |
|
50,000
|
[4],[8],[9],[10],[11],[27],[28] |
| Investment, Identifier [Axis]: Preferred Stock | Healthcare Venture Partners, LLC - Series A Preferred Units of TCSPV Holdings IV, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[6],[7] |
167,000
|
|
|
167,000
|
|
|
|
|
| Amortized Cost |
[3],[5],[6],[7] |
100,000
|
|
|
100,000
|
|
|
|
|
| Investment, Identifier [Axis]: Preferred Stock | New WPCC PARENT, LLC (Series A Preferred Stock) | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
254,801
|
[1],[5],[7],[13],[22] |
|
254,801
|
[1],[5],[7],[13],[22] |
|
231,764
|
[2],[8],[9],[10],[11],[14] |
| Amortized Cost |
|
204,447
|
[3],[5],[7],[13],[22] |
|
204,447
|
[3],[5],[7],[13],[22] |
|
177,122
|
[4],[8],[9],[10],[11],[14] |
| Investment, Identifier [Axis]: Preferred Stock | Shoes West, LLC (d/b/a Taos Footwear) - Preferred Equity | Consumer Goods: Non-Durable |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
121,086
|
[1],[5],[7],[22],[24] |
|
121,086
|
[1],[5],[7],[22],[24] |
|
90,444
|
[2],[8],[9],[10],[11],[28],[29] |
| Amortized Cost |
|
54,808
|
[3],[5],[7],[22],[24] |
|
54,808
|
[3],[5],[7],[22],[24] |
|
50,000
|
[4],[8],[9],[10],[11],[28],[29] |
| Investment, Identifier [Axis]: Preferred Stock | Verify Diagnostic Holdings LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
218,000
|
[1],[5],[6],[7] |
|
218,000
|
[1],[5],[6],[7] |
|
110,000
|
[2],[8],[9],[10],[11] |
| Amortized Cost |
|
100,000
|
[3],[5],[6],[7] |
|
100,000
|
[3],[5],[6],[7] |
|
100,000
|
[4],[8],[9],[10],[11] |
| Investment, Identifier [Axis]: Rising Tide’s Class A Units |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Investment owned, discount (premium) |
|
0
|
|
|
0
|
|
|
(997,560)
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | WatchGuard Technologies, Inc. | High Tech Industries |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[30] |
|
|
|
|
|
|
4,915,366
|
|
| Amortized Cost |
[4],[8],[10],[11],[30] |
|
|
|
|
|
|
4,867,983
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien - First Brands Group 1 | Automotive |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[10],[11],[31] |
|
|
|
|
|
|
3,728,860
|
|
| Amortized Cost |
[4],[10],[11],[31] |
|
|
|
|
|
|
3,902,776
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Amneal Pharmaceuticals LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[10],[11],[31] |
|
|
|
|
|
|
2,960,287
|
|
| Amortized Cost |
[4],[10],[11],[31] |
|
|
|
|
|
|
2,893,170
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Aventiv Technologies, LLC - Second Out Super Priority First Lien Term Loan |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[28],[32] |
|
|
|
|
|
|
84,422
|
|
| Amortized Cost |
[4],[8],[10],[11],[28],[32] |
|
|
|
|
|
|
84,514
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Aventiv Technologies, LLC - Second Out Super Priority First Lien Term Loan Bridge |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
95,193
|
[1],[5],[7],[17],[23] |
|
95,193
|
[1],[5],[7],[17],[23] |
|
95,193
|
[2],[8],[10],[11],[30],[32] |
| Amortized Cost |
|
95,193
|
[3],[5],[7],[17],[23] |
|
95,193
|
[3],[5],[7],[17],[23] |
|
93,354
|
[4],[8],[10],[11],[30],[32] |
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Aventiv Technologies, LLC - Second Out Super Priority First Lien Term Loan | Telecommunications |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[22],[23] |
91,599
|
|
|
91,599
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[22],[23] |
91,599
|
|
|
91,599
|
|
|
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Aventiv Technologies, LLC - Third Out Super Priority First Lien Term Loan | Telecommunications |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[10],[11],[28],[30],[31],[32] |
|
|
|
|
|
|
2,287,376
|
|
| Amortized Cost |
[4],[10],[11],[28],[30],[31],[32] |
|
|
|
|
|
|
3,174,893
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | BCPE North Star US Holdco 2, Inc. | Beverage, Food & Tobacco |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
2,981,169
|
[1],[7],[17],[19],[21] |
|
2,981,169
|
[1],[7],[17],[19],[21] |
|
4,954,278
|
[2],[10],[11],[30],[31] |
| Amortized Cost |
|
2,899,437
|
[3],[7],[17],[19],[21] |
|
2,899,437
|
[3],[7],[17],[19],[21] |
|
4,820,318
|
[4],[10],[11],[30],[31] |
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Burgess Point Purchaser Corporation | Automotive |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
2,577,774
|
[1],[7],[19],[21] |
|
2,577,774
|
[1],[7],[19],[21] |
|
2,551,135
|
[2],[10],[11],[31] |
| Amortized Cost |
|
2,808,579
|
[3],[7],[19],[21] |
|
2,808,579
|
[3],[7],[19],[21] |
|
2,821,071
|
[4],[10],[11],[31] |
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | CareerBuilder, LLC) | Services: Consumer |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[28],[30],[33] |
|
|
|
|
|
|
10,066
|
|
| Amortized Cost |
[4],[8],[10],[11],[28],[30],[33] |
|
|
|
|
|
|
719,993
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | DRI Holding Inc. | Media: Advertising, Printing & Publishing |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
2,396,280
|
[1],[5],[7],[17],[21] |
|
2,396,280
|
[1],[5],[7],[17],[21] |
|
3,413,576
|
[2],[8],[10],[11],[30] |
| Amortized Cost |
|
2,324,677
|
[3],[5],[7],[17],[21] |
|
2,324,677
|
[3],[5],[7],[17],[21] |
|
3,293,835
|
[4],[8],[10],[11],[30] |
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Discovery Point Retreat, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
3,895,000
|
[1],[5],[7],[21] |
|
3,895,000
|
[1],[5],[7],[21] |
|
3,940,000
|
[2],[8],[10],[11] |
| Amortized Cost |
|
3,895,000
|
[3],[5],[7],[21] |
|
3,895,000
|
[3],[5],[7],[21] |
|
3,940,000
|
[4],[8],[10],[11] |
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Druid City Infusion, LLC - First Lien Convertible Note to Druid City Intermediate, Inc. |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
99,257
|
[1],[5],[7],[21],[22] |
|
99,257
|
[1],[5],[7],[21],[22] |
|
80,929
|
[2],[8],[10],[11],[28] |
| Amortized Cost |
|
51,530
|
[3],[5],[7],[21],[22] |
|
51,530
|
[3],[5],[7],[21],[22] |
|
50,752
|
[4],[8],[10],[11],[28] |
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Druid City Infusion, LLC - First Lien Term Loan | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
4,566,228
|
[1],[5],[7],[17],[21] |
|
4,566,228
|
[1],[5],[7],[17],[21] |
|
4,963,043
|
[2],[8],[10],[11] |
| Amortized Cost |
|
4,566,228
|
[3],[5],[7],[17],[21] |
|
4,566,228
|
[3],[5],[7],[17],[21] |
|
4,963,043
|
[4],[8],[10],[11] |
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Emerge Intermediate, Inc. | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[28],[32] |
|
|
|
|
|
|
4,843,302
|
|
| Amortized Cost |
[4],[8],[10],[11],[28],[32] |
|
|
|
|
|
|
5,186,659
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | First Brands Group | Automotive |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[10],[11],[31] |
|
|
|
|
|
|
1,865,771
|
|
| Amortized Cost |
[4],[10],[11],[31] |
|
|
|
|
|
|
1,967,705
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Global Tel*Link Corporation (d/b/a ViaPath Technologies) | Telecommunications |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11] |
|
|
|
|
|
|
4,888,559
|
|
| Amortized Cost |
[4],[8],[10],[11] |
|
|
|
|
|
|
4,844,386
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Imperative Worldwide, LLC (f/k/a MAGNATE WORLDWIDE, LLC) | Transportation: Cargo |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11] |
|
|
|
|
|
|
4,466,250
|
|
| Amortized Cost |
[4],[8],[10],[11] |
|
|
|
|
|
|
4,386,823
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | MoneyGram International, Inc. | Banking |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11] |
|
|
|
|
|
|
2,682,544
|
|
| Amortized Cost |
[4],[8],[10],[11] |
|
|
|
|
|
|
2,926,825
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | New WPCC Parent, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[14] |
|
|
|
|
|
|
825,238
|
|
| Amortized Cost |
[4],[8],[10],[11],[14] |
|
|
|
|
|
|
825,238
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | PlayPower, Inc.-First Lien Revolving Line of Credit - Commitment |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[34] |
|
|
|
|
|
|
0
|
|
| Amortized Cost |
[4],[8],[10],[11],[34] |
|
|
|
|
|
|
0
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | PlayPower, Inc.-First Lien Term Loan | Consumer goods: Durable |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11] |
|
|
|
|
|
|
4,296,202
|
|
| Amortized Cost |
[4],[8],[10],[11] |
|
|
|
|
|
|
4,222,652
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Recovery Solutions Parent, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11] |
|
|
|
|
|
|
681,533
|
|
| Amortized Cost |
[4],[8],[10],[11] |
|
|
|
|
|
|
391,227
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Research Now Group, LLC & Dynata, LLC- First Lien First Out Term Loan | Services: Business |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[30] |
|
|
|
|
|
|
2,923,690
|
|
| Amortized Cost |
[4],[8],[10],[11],[30] |
|
|
|
|
|
|
2,926,551
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Research Now Group, LLC & Dynata, LLC- First Lien Second Out Term Loan |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11] |
|
|
|
|
|
|
1,122,427
|
|
| Amortized Cost |
[4],[8],[10],[11] |
|
|
|
|
|
|
1,284,051
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | S&S Holdings LLC | Wholesale |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[10],[11],[31] |
|
|
|
|
|
|
2,916,144
|
|
| Amortized Cost |
[4],[10],[11],[31] |
|
|
|
|
|
|
2,957,298
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Shoes West, LLC (d/b/a Taos Footwear) - First Lien Convertible Note to Taos Footwear |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[28],[29] |
|
|
|
|
|
|
252,767
|
|
| Amortized Cost |
[4],[8],[10],[11],[28],[29] |
|
|
|
|
|
|
201,762
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Shoes West, LLC (d/b/a Taos Footwear) - First Lien Term Loan | Consumer Goods: Non-Durable |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[29] |
|
|
|
|
|
|
4,726,250
|
|
| Amortized Cost |
[4],[8],[10],[11],[29] |
|
|
|
|
|
|
4,726,250
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | Verify Diagnostics, LLC | Healthcare & Pharmaceuticals |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[35] |
|
|
|
|
|
|
2,450,000
|
|
| Amortized Cost |
[4],[8],[10],[11],[35] |
|
|
|
|
|
|
2,500,000
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-First Lien | iQOR Holdings, Inc. | Services: Consumer |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11] |
|
|
|
|
|
|
4,570,447
|
|
| Amortized Cost |
[4],[8],[10],[11] |
|
|
|
|
|
|
4,570,447
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-Second Lien | QC Holdings TopCo, LLC - Delayed Draw Term Loan | Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[17],[22],[36],[37] |
113,527
|
|
|
113,527
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[17],[22],[36],[37] |
113,527
|
|
|
113,527
|
|
|
|
|
| Investment, Identifier [Axis]: Senior Secured Loans-Second Lien | QC Holdings, LLC | Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
2,500,000
|
[1],[5],[7],[15],[21],[22],[36] |
|
2,500,000
|
[1],[5],[7],[15],[21],[22],[36] |
|
2,500,000
|
[2],[8],[10],[11],[16],[38] |
| Amortized Cost |
|
2,500,000
|
[3],[5],[7],[15],[21],[22],[36] |
|
2,500,000
|
[3],[5],[7],[15],[21],[22],[36] |
|
2,500,000
|
[4],[8],[10],[11],[16],[38] |
| Investment, Identifier [Axis]: Senior Secured Loans-Second Lien | Shutterfly Finance, LLC | Media: Diversified and Production |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[10],[11],[28],[31] |
|
|
|
|
|
|
1,749,570
|
|
| Amortized Cost |
[4],[10],[11],[28],[31] |
|
|
|
|
|
|
1,839,325
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Apidos CLO XXIV | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39] |
|
|
|
|
|
|
77,000
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39] |
|
|
|
|
|
|
102,206
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Apidos CLO XXVI | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[19],[40],[41] |
14,125
|
|
|
14,125
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[19],[40],[41] |
13,974
|
|
|
13,974
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Apidos CLO XXVI(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
80,000
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
96,650
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Carlyle Global Market Strategies CLO 2017-5, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Carlyle Global Market Strategies CLO 2017-5, Ltd.(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
9,700
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
4,281
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Galaxy XIX CLO, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Galaxy XIX CLO, Ltd.(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
0
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
0
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | GoldenTree Loan Opportunities IX, Ltd.(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
0
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
0
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Madison Park Funding XIII, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[19],[40],[41] |
8,675
|
|
|
8,675
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Madison Park Funding XIII, Ltd.(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
12,875
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
0
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Madison Park Funding XIV, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39] |
|
|
|
|
|
|
73,625
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39] |
|
|
|
|
|
|
95,293
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | OZLM XII, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | OZLM XII, Ltd.(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
0
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
0
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners 30, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners 30, Ltd.(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
16,340
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
7,365
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners 31, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[19],[40],[41] |
0
|
|
|
0
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners 31, Ltd.(v) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
2,200
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39],[42] |
|
|
|
|
|
|
2,425
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners 36, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
4,050
|
[1],[5],[7],[15],[19],[41] |
|
4,050
|
[1],[5],[7],[15],[19],[41] |
|
70,950
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
4,092
|
[3],[5],[7],[15],[19],[41] |
|
4,092
|
[3],[5],[7],[15],[19],[41] |
|
90,770
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners 39, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
5,600
|
[1],[5],[7],[15],[19],[41] |
|
5,600
|
[1],[5],[7],[15],[19],[41] |
|
57,300
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
5,650
|
[3],[5],[7],[15],[19],[41] |
|
5,650
|
[3],[5],[7],[15],[19],[41] |
|
76,834
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners XIV, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[31],[39] |
|
|
|
|
|
|
0
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[31],[39] |
|
|
|
|
|
|
0
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners XV, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
60,350
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
60,795
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners XXI, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[17],[19],[41] |
1,589
|
|
|
1,589
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[17],[19],[41] |
1,641
|
|
|
1,641
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Octagon Investment Partners XXI, Ltd.(j) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[30],[31],[39] |
|
|
|
|
|
|
86,576
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[30],[31],[39] |
|
|
|
|
|
|
112,058
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Sound Point CLO II, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
750
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
907
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Sound Point CLO VII-R, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
0
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
0
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Sound Point CLO XVIII, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
22,425
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
30,954
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | THL Credit Wind River 2013-1 CLO, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
10,693
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
14,976
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Venture XXXIV CLO, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
0
|
[1],[5],[7],[15],[19],[41] |
|
54,800
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
0
|
[3],[5],[7],[15],[19],[41] |
|
73,912
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Voya CLO 2016-1, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
17,800
|
[1],[5],[7],[15],[19],[41] |
|
17,800
|
[1],[5],[7],[15],[19],[41] |
|
43,925
|
[2],[8],[10],[11],[16],[31],[39] |
| Amortized Cost |
|
23,387
|
[3],[5],[7],[15],[19],[41] |
|
23,387
|
[3],[5],[7],[15],[19],[41] |
|
55,518
|
[4],[8],[10],[11],[16],[31],[39] |
| Investment, Identifier [Axis]: Structured Subordinated Notes | Voya IM CLO 2013-1, Ltd. | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[1],[5],[7],[15],[17],[19],[41] |
16,615
|
|
|
16,615
|
|
|
|
|
| Amortized Cost |
[3],[5],[7],[15],[17],[19],[41] |
21,657
|
|
|
21,657
|
|
|
|
|
| Investment, Identifier [Axis]: Structured Subordinated Notes | Voya IM CLO 2013-1, Ltd.(j) | Structured Finance |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
[2],[8],[10],[11],[16],[30],[31],[39] |
|
|
|
|
|
|
29,752
|
|
| Amortized Cost |
[4],[8],[10],[11],[16],[30],[31],[39] |
|
|
|
|
|
|
39,977
|
|
| Investment, Identifier [Axis]: WatchGuard Technologies Inc | First Lien Term Loan |
|
|
|
|
|
|
|
|
|
| Schedule of Investments [Line Items] |
|
|
|
|
|
|
|
|
|
| Investment owned, discount (premium) |
|
41,809
|
|
|
41,809
|
|
|
$ 47,382
|
|
| Non-control/non-affiliate investments (amortized cost of $69,812,379 and $88,404,806, respectively) (Notes 7 and 8) |
|
$ 3,407,773
|
|
|
$ 3,407,773
|
|
|
|
|
|
|